homocysteine and Carcinoma, Ductal, Pancreatic

homocysteine has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, K; Esaki, M; Hirose, H; Ikeda, M; Kosuge, T; Morizane, C; Ohnami, S; Okusaka, T; Saito, D; Saito, I; Sakamoto, H; Sakamoto, Y; Sato, Y; Shimada, K; Sugimura, H; Ueno, H; Yoshida, T; Yoshimura, K1

Other Studies

1 other study(ies) available for homocysteine and Carcinoma, Ductal, Pancreatic

ArticleYear
His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
    Gastroenterology, 2008, Volume: 135, Issue:2

    Topics: Adult; Aged; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cell Line; Culture Media; DNA Methylation; Female; Ferredoxin-NADP Reductase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Homocysteine; Humans; Japan; Long Interspersed Nucleotide Elements; Male; Middle Aged; Mutation, Missense; Odds Ratio; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Transfection

2008